| 摘要 |
FIELD: medicine; pharmacology. ^ SUBSTANCE: invention refers to medical products of antiischemic and hypolipidemic activity and can be used as new agent for correction of lipidic metabolic disorder to prevent and treat dyslipidemia, ischemic heart disease (IHD), and as rehabilitation agent at postinfarction conditions. Agent of antiischemic and hypolipidemic activity represents ecdysteroids-containing substance extracted from aerial saw-wort Serratula coronata L. (Asteraceae), containing mixed 20-hydroxyecdysone in amount not less than 75% and 25S-inocosterone in amount not less than 10%. ^ EFFECT: evident hypolipidemic activity and considerable reduction in common lipid, cholesterol and triglyceride content. ^ 7 ex, 19 tbl, 24 dwg |
